Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan. | Front Pharmacol | 2024 | 38655187 | PubTator, text mining | PubMed |
| Expression and localization of apelin and apelin receptor protein in the oviduct of letrozole-induced hyperandrogenized mice. | Cell Biol Int | 2024 | 38634302 | PubTator, text mining | PubMed |
| Deorphanization of G Protein Coupled Receptors: A Historical Perspective. | Mol Pharmacol | 2024 | 38622017 | PubTator, text mining | PubMed |
| Serum apelin as a potential biomarker for infantile hemangiomas. | Pediatr Blood Cancer | 2024 | 38602300 | PubTator, text mining | PubMed |
| Diagnostic and prognostic significance of apelin-13, APJ for sepsis in the emergency department: A prospective study. | Heliyon | 2024 | 38590887 | PubTator, text mining | PubMed |
| Neuroprotective effect of apelin-13 and other apelin forms-a review. | Pharmacol Rep | 2024 | 38568371 | PubTator, text mining | PubMed |
| APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway. | Arch Biochem Biophys | 2024 | 38561035 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38508477 | PubTator, text mining | PubMed |
| Predicting feature genes correlated with immune infiltration in patients with abdominal aortic aneurysm based on machine learning algorithms. | Sci Rep | 2024 | 38431726 | PubTator, text mining | PubMed |
| Structure-based design of non-hypertrophic apelin receptor modulator. | Cell | 2024 | 38428423 | Swiss-Prot, curated | PubMed |
| A high-resolution view of the heterogeneous aging endothelium. | Angiogenesis | 2024 | 38324119 | PubTator, text mining | PubMed |
| Serum Elabela expression is decreased in hypertensive patients and could be associated with the progression of hypertensive renal damage. | Eur J Med Res | 2024 | 38297369 | PubTator, text mining | PubMed |
| Localized apelin-17 analogue-bicelle interactions as a facilitator of membrane-catalyzed receptor recognition and binding. | Biochim Biophys Acta Biomembr | 2024 | 38278504 | PubTator, text mining | PubMed |
| The Role of Adipokines in the Control of Pituitary Functions. | Animals (Basel) | 2024 | 38275812 | PubTator, text mining | PubMed |
| The Role of Adipokines in Tumor Progression and Its Association with Obesity. | Biomedicines | 2024 | 38255203 | PubTator, text mining | PubMed |
| The Apelin/APJ System: A Potential Therapeutic Target for Sepsis. | J Inflamm Res | 2024 | 38250143 | PubTator, text mining | PubMed |
| Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers. | Cell Commun Signal | 2024 | 38238841 | PubTator, text mining | PubMed |
| LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea. | Epigenetics | 2024 | 38232183 | PubTator, text mining | PubMed |
| Trends in Acupuncture Therapy for Microcirculation and Hemorheology from 1998 to 2023: A Bibliometric and Visualized Study. | J Pain Res | 2024 | 38223661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=9